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Abstract 
Background: The rise of chronic diseases such as diabetes, cardiovascular disease, and obesity has 
become a great concern in the medical community. Incorporating Opuntia into people’s diets may allow 
patients a natural alternative to supplement traditional medicine in order to combat these diseases. The 
purpose of this review is to investigate the effect of Opuntia on postprandial glucose levels. 
Methods: A comprehensive search of online medical literature was performed using MEDLINE-PubMed, 
EBMR Multifile, and CINAHL. Keywords used included: prickly pear, nopal, Opuntia, and diabetes. Inclusion 
criteria required human studies, studies published in the English language, and studies within the last 15 
years. 
Results: Three articles met eligibility criteria. Two of the articles were cohort studies while one of the 
studies was a randomized control trial. There are consistent results regarding a significant decrease in 
postprandial insulin and blood glucose levels. The overall quality of the studies is low due to some 
limitations (see Table I). Further studies are needed to address these limitations, and improve the quality 
of evidence in regards to the effects of Opuntia on postprandial blood glucose. 
Conclusion: Studies investigating the effects of Opuntia on postprandial glucose levels show promising 
results of safely lowering postprandial blood glucose and insulin levels acutely. However, more research 
is needed with larger randomized controlled studies to provide additional evidence to support these 
results. Additional research is also needed to determine the long-term effects of Opuntia, and its 
capability to complement and potentially replace traditional hypoglycemic medications. Until then, 
medical providers can discuss Opuntia’s natural hypoglycemic effects with patients to help reduce 
progression of chronic disease. 
Degree Type 
Capstone Project 
Degree Name 
Master of Science in Physician Assistant Studies 
Keywords 
Prickly pear, nopal, Opuntia, postprandial, diabetes. 
This capstone project is available at CommonKnowledge: https://commons.pacificu.edu/pa/627 
Copyright and terms of use 
If you have downloaded this document directly from the web or from CommonKnowledge, see 
the “Rights” section on the previous page for the terms of use. 
If you have received this document through an interlibrary loan/document delivery service, the 
following terms of use apply: 
Copyright in this work is held by the author(s). You may download or print any portion of this 
document for personal use only, or for any use that is allowed by fair use (Title 17, §107 U.S.C.). 
Except for personal or fair use, you or your borrowing library may not reproduce, remix, 
republish, post, transmit, or distribute this document, or any portion thereof, without the 
permission of the copyright owner. [Note: If this document is licensed under a Creative 
Commons license (see “Rights” on the previous page) which allows broader usage rights, your 
use is governed by the terms of that license.] 
Inquiries regarding further use of these materials should be addressed to: CommonKnowledge 
Rights, Pacific University Library, 2043 College Way, Forest Grove, OR 97116, (503) 352-7209. 
Email inquiries may be directed to:.copyright@pacificu.edu 
 - 1 -  
 
The Effects of Opuntia (Cactaceae) on Lowering 
Postprandial Blood Glucose 
 
 
 
 
Megan Aaseby 
 
 
 
 
 
 
 
 
 
 
 
 
A Clinical Graduate Project Submitted to the Faculty of the 
School of Physician Assistant Studies 
Pacific University 
Hillsboro, OR 
For the Masters of Science in Physician Assistant Studies Degree 
 August 12, 2017 
 
 
Faculty Advisor: Brent Norris, PA-C, MPAS 
Clinical Graduate Project Coordinator: Annjanette Sommers, PA-C, MS  
 - 2 -  
Biography 
 
Megan Aaseby was raised in Iowa and graduated from Western Illinois 
University in 2011 with a degree in Marketing. She worked for a 
government IT command center during her undergrad years. After 
completion of her undergraduate degree, she moved to New York and 
worked as a business analyst in information technology. After working 
in IT for a couple of years she decided to make the transition to 
medicine and relocated to North Carolina to pursue additional 
coursework in Biology. She also volunteered at the emergency 
department and neonatal intensive care unit, and worked as a CNA 
before starting PA school.  
  
 - 3 -  
Abstract   
 
Background: The rise of chronic diseases such as diabetes, 
cardiovascular disease, and obesity has become a great concern in the 
medical community. Incorporating Opuntia into people’s diets may 
allow patients a natural alternative to supplement traditional medicine 
in order to combat these diseases. The purpose of this review is to 
investigate the effect of Opuntia on postprandial glucose levels.  
 
Methods:  A comprehensive search of online medical literature was 
performed using MEDLINE-PubMed, EBMR Multifile, and CINAHL. 
Keywords used included: prickly pear, nopal, Opuntia, and diabetes. 
Inclusion criteria required human studies, studies published in the 
English language, and studies within the last 15 years.  
 
Results:  Three articles met eligibility criteria. Two of the articles were 
cohort studies while one of the studies was a randomized control trial. 
There are consistent results regarding a significant decrease in 
postprandial insulin and blood glucose levels. The overall quality of the 
studies is low due to some limitations (see Table I). Further studies 
are needed to address these limitations, and improve the quality of 
evidence in regards to the effects of Opuntia on postprandial blood 
glucose.  
 
Conclusion: Studies investigating the effects of Opuntia on 
postprandial glucose levels show promising results of safely lowering 
postprandial blood glucose and insulin levels acutely. However, more 
research is needed with larger randomized controlled studies to 
provide additional evidence to support these results. Additional 
research is also needed to determine the long-term effects of Opuntia, 
and its capability to complement and potentially replace traditional 
hypoglycemic medications. Until then, medical providers can discuss 
Opuntia’s natural hypoglycemic effects with patients to help reduce 
progression of chronic disease.  
 
Keywords: Prickly pear, nopal, Opuntia, postprandial, diabetes.  
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The Effects of Opuntia (Cactaceae) on Lowering 
Postprandial Blood Glucose 
BACKGROUND 
The cactus Opuntia, which is also known as prickly pear cactus, 
Indian fig cactus, or nopal is native to central Mexico and is a 
commonly eaten vegetable. The cladodes, commonly called pads, 
nopalitos, or tunas, are traditionally used for the treatment of diabetes 
in traditional Mexican medicine. In the late 1980’s, Frati-Munari et al1 
was one of the first to investigate in humans the hypoglycemic effect 
of prickly pear pectin in different patient groups. Several studies2-4 
have been performed which support the hypoglycemic effects of 
Opuntia, but few have focused on the effects of Opuntia on 
postprandial blood glucose.  
With the rise of chronic disease such as diabetes, cardiovascular 
disease, and obesity there has been a great concern in the medical 
community about the limited resources for prevention and treatment. 
Consuming high-calorie meals can lead to exaggerated postprandial 
peaks in blood glucose and lipids in diabetics which results in 
inflammation and endothelial dysfunction.5 Incorporating Opuntia into 
people’s diets may allow patients a natural alternative to supplement 
traditional medicine. Opuntia can be a safe way to counteract 
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increases in postprandial blood glucose to prevent further health 
complications of diabetes and cardiovascular disease.  
Clinicians need to be knowledgeable about herbal remedies to 
provide guidance to patients who are looking for traditional medicine 
options to improve adherence and if possible to reduce progression of 
chronic diseases. The purpose of this review is to investigate the effect 
of Opuntia on postprandial glucose levels, and to determine if Opuntia 
should be recommended as a natural alternative for lowering 
postprandial glucose.  
METHODS 
A comprehensive search of online medical literature was 
performed using MEDLINE-PubMed, EBMR Multifile, and CINAHL. The 
keywords used during this search included: prickly pear, nopal, 
Opuntia, and diabetes. Eligibility criteria required were human studies, 
studies published in the English language, and studies within the last 
15 years. Other inclusion criteria required patients that consumed 
Opuntia. Studies were excluded if they did not include postprandial 
data on blood glucose and insulin. The quality of relevant articles was 
evaluated using the Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) Working Group guidelines.6 
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RESULTS 
An initial search of MEDLINE-Pubmed yielded 60 articles for 
review. After screening the results for relevant articles, 3 of the 
articles1,5,7 met eligibility criteria. One of the studies7 was a 
randomized control trial, while 2 of the articles were cohort studies1,5. 
An initial search on EBMR Multifile yielded 5 articles. After screening 
the results only one article5 met the criteria, but this study already 
appeared in the MEDLINE-Pubmed results. A search on CINAHL 
revealed 18 results. After screening the results only one article5 met 
the criteria, but the one already appeared in the MEDLINE-Pubmed 
results. In total, 3 articles were assessed for this systematic review 
(See Tables I-IV). 
Godard et al (2010)  
This 16-week double-blind placebo controlled study7 was 
designed to evaluate the acute and chronic effects of OpunDiaTM 
(Opuntia ficus-indica) in 29 pre-diabetic obese male and female 
subjects. Inclusion criteria was a body mass index 30-35 kg/m2, and 
an oral glucose tolerance test (OGTT) with a 2-hour OGTT value 
between 140 and 199 mg/dL. Subjects were excluded if they had any 
known health problems such as hypertension, kidney, or liver 
problems or were pregnant or nursing women. In addition, subjects 
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regularly taking any prescription or non-prescription drugs including 
dietary supplements were excluded.7 
 The participants (ages 20-50 years) were randomly assigned to 
1 of 2 groups and given a 16-week supply of either 200mg OpunDiaTM 
(n=15) or placebo (n=14). The proprietary product OpunDiaTM is a 
blend of Opuntia ficus-indica cladode and fruit skin extract. All the 
plant materials of Opuntia ficus-indica were obtained from a US 
American-based cultivation. The OpunDiaTM supplement consisted of 
capsules containing 200 mg OpunDiaTM. Capsules containing 200 mg 
microcrystalline cellulose were used as a matched-placebo.7  
Baseline and post 16-week concentrations of glucose, insulin, 
high sensitivity C-reactive protein (hs-CRP), adiponectin, proinsulin, 
Hb1Ac, adiponectin cholesterol, and comprehensive metabolic panel 
were collected. Analysis of variance (ANOVA) was used repeatedly 
throughout the study to determine any significant interactions between 
group and time.7  
During the acute study phase, an OGTT with a bolus load (400 
mg) of OpunDiaTM was given 30 minutes (min) before ingestion of a 75 
g glucose solution. Blood samples were drawn before the bolus 
administration, before the ingestion of the glucose solution, and every 
30 min thereafter for 120 min. Results were analyzed with an overall 
significance level set at 5%. There was a statistical significant 
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difference (P<0.05) in blood glucose concentrations between the pre-
diabetic OGTT values and the OGTT values after OpunDiaTM bolus 
administration after 60 min (206 + 37 mg/dL versus 189 + 38 mg/dL), 
90 min (185+ 34 mg/dL versus 170 + 35 mg/dL) and 120 min (159 + 
18 mg/dL versus 149 + 25 mg/dL).7  
For the chronic study phase, the following blood parameters 
were determined via enzyme-linked immunosorbent essay (ELISA) kits 
before and after the 16-week supplementation period: OGTT, plasma 
levels of glucose, insulin, hs-CRP, adiponectin, proinsulin, and 
glycosylated hemoglobin. The OpunDiaTM group had significantly lower 
blood glucose concentrations (via the OGTT) at 60, 90, and 120 min 
post-intervention compared to pre-intervention. However, the placebo 
group also demonstrated significantly lower blood glucose 
concentrations at the 60 and 120 min time points post-intervention 
compared to pre-intervention. There was no between-group difference 
found with any of the other blood chemistry variables.7  
 The chronic phase of the study did reveal the safety of 
OpunDiaTM. The following blood parameters were determined before 
and after the 16-week supplementation period to determine the safety 
of OpunDiaTM: blood urea nitrogen (BUN), creatinine, glomerular 
filtration rate (GFR), BUN/creatinine ratio, protein total, albumin, 
globulin, albumin/globulin ratio, bilirubin total, white blood cell (WBC) 
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count, red blood cell (RBC) count, hemoglobin, hematocrit, mean cell 
volume (MCV), mean cell hemoglobin (MCH), mean cell hemoglobin 
concentration (MCHC), red cell distribution width (RDW), platelet 
count, and WBC differential. The study showed neither relevant side 
effects or negative side effects on blood, liver or kidney parameters.7  
Lopez-Romero et al (2014)  
 This was a cohort study5 done to determine the effect of nopal 
on postprandial glucose in Mexican patients with type 2 diabetes. Two 
studies were performed. Each study used a separate group of 
participants. All participants completed a 12-hour overnight fast and 
consumed the test meal(s) in the morning within 10 min.5  
Capillary blood samples were taken using a finger-stick to 
measure glucose in healthy participants intermittently before and at 
15, 30, 45, 60, 90, and 120 min after consuming the test meals. 
Diabetic patients received an additional sample collection at 150 min. 
In addition, venous blood samples obtained at the same intervals as 
capillary blood to measure serum insulin, plasma glucose-dependent 
insulinotropic peptide (GIP), glucagon-like peptide-1 (GLP-1) and 
antioxidant activity. A P value of <0.05 was considered to be 
significant.5  
 The first study was performed to determine the glycemic index 
of nopal. Participants included 7 healthy, nonsmoking, nonmedicated, 
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normal-weight volunteers (3 men and 4 women) with a standard error 
of mean [SEM]= 26.3+1.2 years of age and a mean+SEM body mass 
index (BMI) of 23.5+0.8 kg/m2. The glycemic index, insulinemic 
index, GIP index and GLP-1 index were calculated after participants 
consumed 50 g of available carbohydrates from glucose or dehydrated 
nopal. The results showed ingestion of 50 g of available carbohydrates 
from nopal resulted in a significant reduction (P <0.001) in the 
incremental area under the curve (IAUC) of blood glucose with respect 
to the 50 g of glucose, which resulted in a low glycemic index for 
nopal. As for insulin, the IAUC for nopal was significantly different (P 
<0.05), which resulted in a insulinemic index that was also considered 
low.5  
 The second study was performed to evaluate the effect of nopal 
on postprandial blood glucose after the consumption of 2 different 
types of breakfasts with or without 300 g steamed nopal. There was a 
washout period of 1 week between meals. Participants included 14 
diabetics (4 men and 10 women) who were diagnosed with type 2 
diabetes less than 8 years before enrollment. Subjects were between 
40-60 years old with a BMI <30. This study excluded subjects with 
dyslipidemia, hypertension, or severe hypoglycemic episodes during 
the past year. Their fasting serum glucose concentration were <8%. 
The only treatments the diabetics were receiving was metformin. 
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However, the day of the study, participants were instructed not to take 
their morning doses of metformin.5  
 Seven non-diabetics were recruited for this study for the control 
group. This group included 4 men and 3 women (25-54 years old) with 
a BMI <25 for the past 6 months. Exclusion criteria for this control 
group included current cigarette smokers, presence of known medical 
problem or currently being on any medication.5  
 This study evaluated the metabolic effect of steamed nopal on 
postprandial peak of glucose, insulin, GIP, and antioxidant activity 
after the consumption of a high-carbohydrate breakfast (HCB) or high-
soy-protein breakfast (HSPB). The HCB contained 300 kilocalorie (kcal) 
and comprised of 89% carbohydrates, 6% protein, and 5% fat. The 
HSPB contained 344 kcal and comprised of 42.4% carbohydrates, 
40.7% protein and 16.9% fat. The HCB+nopal and the HSPB+nopal 
contained the addition of 300 g steamed nopal.5  
Results show that patients with type 2 diabetes had a higher 
fasting blood glucose concentration compared with healthy individuals. 
Patients with type 2 diabetes who consumed the HSPB avoided 
postprandial blood glucose peaks. HSPB+nopal significantly reduced 
the postprandial peaks of GIP concentration at 30-45 min and 
increased the antioxidant activity after 2 hours measured by the 2,2-
diphenyl-1-picrilhidracyl method.5 
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Patients with type 2 diabetes who consumed the HCB+nopal 
were significantly lower area under the curve for glucose than for 
insulin. HCB+nopal significantly decreased the postprandial peaks of 
glucose at 45 and 60 min (P <0.01). The IAUC for HCB+nopal was 
significantly lower than the group with an HCB (<0.001).5  
The addition of nopal significantly decreased the postprandial 
peaks of glucose at 30, 45 and 60 min (P <0.05). There was no 
difference in the IAUC for glucose in healthy participants after the 
consumption of both breakfasts.5  
 These findings suggest that nopal could reduce postprandial 
blood glucose, serum insulin, and plasma GIP peaks, as well as 
increase antioxidant activity in healthy people and patients with type 2 
diabetes.5  
Wolfram et al (2002)  
In this cohort study,1 the goal was to determine the effect of 
prickly pear (Opuntia robusta) on glucose and lipid metabolism in lean, 
non-diabetics with hyperlipidemia. Twenty-four non-diabetic, non-
obese males (37-55 years old) with normal BMI were split up into 2 
groups. Group A consisted of 12 men with primary isolated 
hypercholesterolemia, and Group B consisted of 12 men with combined 
hypercholesterolemia and hyperlipidemia.1  
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In phase I, an 8-week 7506 kilojoules (KJ) step-1 diet was 
completed. The diet provided to participants was constant through all 
study phases.  In phase II, 625 KJ (50% from fibers and 50% from 
carbohydrates) were replaced by Opuntia robusta edible pulp 
(250g/day) for 8 additional weeks. The prickly pear was locally grown. 
Blood was drawn at the beginning and end of each phase. Additionally, 
blood was drawn at the end of phase II in the morning after a 14-hour 
overnight fast. Blood chemistry included: lipids, lipoproteins, 
apolipoproteins, lipoprotein-a, fibrinogen, uric acid, blood glucose and 
serum insulin. A confidence level of 95% and t-tests were performed. 
P-values smaller than 0.05 were considered statistically significant.1  
The comparison of the mean values at the end of phase I and II 
showed the prickly pear caused a decrease of blood glucose (11%), 
insulin (11%), total cholesterol (12%), low-density lipoprotein-
cholesterol (15%), apolipoprotein B (9%), triglycerides (12%), 
fibrinogen (11%), and uric acid (10%). Meanwhile, body weight, high-
density lipoprotein-cholesterol, apolipoprotein A-1, and lipoprotein-a 
remained unchanged.1  
 There was a significant decrease in both groups between the 
mean values of phase I and II including blood glucose, total 
cholesterol (CH), low-density lipoprotein cholesterol (LDL-CH), 
apolipoprotein B (apo B), fibrinogen, and uric acid. Triglyceride (TG) 
 - 16 -  
levels only showed a significant decrease in Group B, while high-
density lipoprotein cholesterol (HDL-CH) increased significantly 
(p<0.01) only in group A. Insulin levels were significantly lowered in 
group A, while group B showed no significant changes in insulin. No 
changes in body weight or BMI were observed during the study.1  
DISCUSSION 
The modern western diet and lack of physical activity has 
created an environment for unhealthy lifestyles that is leading to a rise 
in chronic diseases such as diabetes, cardiovascular disease, and 
obesity. Uncontrolled postprandial blood glucose levels are a serious 
health problem for individuals with chronic diseases. Clinicians and 
patients are in need of an easy and cost effective solution to this 
problem.  
Some patients are more likely to adhere to natural remedies 
than take a pill. In the last two decades, complementary and 
alternative medicine (CAM) has increased significantly.8 The National 
Center for Complementary and Alternative Medicine (NCCAM) defines 
CAM as “healthcare and medical practices that are not currently an 
integral part of conventional medicine.”8,9 Commonly used CAMs are 
herbal therapies, multivitamins, prayer, acupuncture, yoga and 
aromatherapy, among others. Patients with chronic conditions such as 
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diabetes, hypertension, cancer, arthritis, and asthma are more likely 
to use CAM than the general public.9 Although many patients with 
chronic conditions use CAM in attempt to improve their chronic 
conditions, there are few studies that analyze the prevalence and 
types of CAMs available, as well as their use among various ethnic and 
cultural backgrounds. 
Nopal is a commonly used food and traditional remedy among 
people of Mexican descent. Many studies have recognized prickly 
pear’s effects as an herbal hypoglycemic agent but few studies have 
examined its postprandial glycemic effects. These 3 studies1,5,7 
demonstrate that prickly pear may be efficacious and likely safe in 
lowering postprandial blood glucose in both type 2 diabetics and non-
diabetics, and has significant benefit on human lipid metabolism.1 
Godard et al7 had a statistically significant decrease (P<0.05) in blood 
glucose concentrations after the consumption of OpunDiaTM with 
prediabetic patients at the 60, 90 and 120 min time points (see Table 
II). Lopez-Romero et al5 study had a statistically significant decrease 
(P<0.05) in postprandial blood glucose at 30, 45 and 60 min in 
diabetic patients that consumed HCB+nopal for breakfast (see Table 
III). Wolfram et al1 study also found a statistically significant decrease 
(p<0.005) in blood glucose among non-diabetics with hyperlipidemia 
with and without hypercholesterolemia (see Table IV).   
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Nopal was shown to also decrease insulin levels in diabetics,5 
and non-diabetic hyperlipidemia patients,1 but did not have a 
statistically significant effect on insulin in pre-diabetics7 or 
hyperlipidemia plus hypercholesterolemia patients.1 Although the 
mechanism of action of prickly pear’s hypoglycemic effects are 
unknown, there is significant decrease of serum insulin occurring 
throughout these studies that may suggest prickly pear increases a 
cell’s sensitivity to insulin. In the Lopez-Romero et al5 study their 
research suggest that nopal could regulate blood glucose and serum 
insulin concentrations by modulating GIP levels after finding nopal’s 
low glycemic index and insulinemic index were associated with a 
dramatic reduction of the IAUC for the total plasma GIP 
concentration.5 
It is difficult to compare which participants had the largest 
decrease due to the variability of the studies, but when taking into 
consideration all the variables, prickly pear appeared to be more 
effective in pre-diabetics and diabetics than healthy, non-diabetics. 
Since the quality of these studies is low, prickly pears have potential to 
make an impact on reducing the effects of chronic disease. Thus, 
clinicians could consider recommending Opuntia be added to diets in 
patients with chronic diseases such as diabetes, pre-diabetes, obesity, 
heart disease, hyperlipidemia, and hypercholesterolemia. 
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The main limitations of the studies included in this systematic 
review are lack of large sample-sizes, lack of randomization in the 
placebo controlled trial, and lack of control groups. Although the 
studies were consistent with the Opuntia samples used in the studies, 
each of the 3 studies consumed a different type of Opuntia that was 
prepared and served in different amounts between the studies.  
Although nopal is a widely consumed vegetable that is 
considered safe, more research is needed to determine its safety in 
individuals with severe liver or kidney disease and pregnant or nursing 
women. Further research is also needed to investigate effects of 
prickly pear. More randomized controlled trials (RCTs) are needed to 
validate these results, determine the long-term effects of prickly pear, 
and test if an increased dose may cause more noticeable effects on 
postprandial blood glucose. Additional research is needed to determine 
if Opuntia can be used to substitute common medications prescribed 
for type II diabetics, such as metformin. Recommending Opuntia in 
conjunction with clinical medicine may increase patient adherence 
among those that are hesitant to take medication or drastically change 
their diet, and reduce undesired outcomes caused by diabetes.  
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CONCLUSION 
Overall, all 3 studies1,5,7 show the acute postprandial blood 
glucose lowering effects on obese pre-diabetics, type II diabetics, and 
non-diabetics. It also showed the long-term safety of Opuntia, thus 
supporting its traditional use for blood glucose management. Studies 
investigating the effects of Opuntia on postprandial glucose levels 
show promising results on safely lowering postprandial blood glucose 
and insulin levels acutely. However, more research is needed with 
larger randomized controlled studies to provide additional evidence to 
support these results.  
 Additional research is also needed to determine the long-term 
effects of Opuntia, and its capability to complement and potentially 
replace traditional hypoglycemic medications. Until then, medical 
providers can discuss Opuntia’s natural hypoglycemic effects with 
patients to help reduce progression of chronic disease. 
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Table I. Quality Assessment of Reviewed Articles 
 
 
 
 
  
Study Design 
Downgrade Criteria 
Upgrade 
Criteria 
Quality 
Limitations Indirectness Inconsistency Imprecision 
Publication 
bias 
Godard et al7 RCT Very Seriousa,b Not Serious Not Serious Not Serious Unlikelyc None 
Low 
 
Lopez-Romero et 
al5 
Cohort Very Seriousb Not Serious Not Serious Not Serious Unlikely None 
Very 
Low 
Wolfram et al1 Cohort Very Seriousb,d Not Serious Not Serious Not Serious Unlikely None 
Very 
Low 
a Study lacks randomization. 
b Small sample size. 
c The funding for this research is not disclosed, nor is there a disclaimer from the makers of OpunDiaTM. 
d Study lacks a control. 
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Summary Findings  
 
Table II. Godard et al (2010)7 
 
Study Characteristics 
Outcomes: Comparing changes in outcomes between data  
(n.s = not significant; *Significant p-values <0.0.5) 
Groups Patient Population 
Age 
in 
Years 
Study 
Length 
Prickly Pear 
Supplement 
Blood 
Glucose 
(mmol/L) 
at 0 min 
Blood 
Glucose 
(mmol/L) 
at 30 min 
Blood Glucose 
(mmol/L) 
at 60 min 
Blood Glucose 
(mmol/L) 
at 90 min 
Blood Glucose 
(mmol/L) 
at 120 min 
Acute 
Phase 
n=15 
Twenty-nine pre-diabetic 
male and female 
participants with no 
known health problems 
that are not taking any 
prescription or non-
prescription drugs 
20-50 
years 
120 min 
400 mg OpunDiaTM 
bolus 
n.s. n.s. 
205.92 + 36.90 mg/dL 
vs 188.84 + 38.43 
mg/dL*a 
184.55 + 33.67 mg/dL 
vs 169.74 + 35.16 
mg/dL* 
159.24 + 17.85 mg/dL 
vs 148.89 + 24.86 
mg/dL* 
Chronic 
Phase 
n=15 
16 weeks 
2x200 mg 
OpunDiaTM capsule 
n.s. n.s. *b,c *c *b,c 
a Blood glucose concentrations between the pre-OGTT values and the OGTT values after OpunDiaTM bolus administration. 
b The intervention group experienced significantly lower blood glucose concentration at 60 min, 90 min and 120 min time points compared to pre-intervention. However, the placebo group also 
demonstrated significant lower blood glucose concentrations at 60 and 120 min post intervention compared to pre-intervention.   
c Pre-value OpunDiaTM and post-value OpunDiaTM glucose statistical data not included in the study. 
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Table III. Lopez-Romero et al (2014)5 
 
Study Characteristics 
Outcomes: Comparing changes in outcomes between data  
(n.s = not significant; *Significant p-values <0.05; **Significant p-values <0.01; ***Significant 
p-values <0.001) 
Groups Patient Population 
Age in 
Years+SEM 
Prickly Pear 
Supplement 
Blood 
Samples 
Blood Glucose (mg/dL) Insulin (pmol/L) GIP (pg/mL) 
Study 1 
n=7 
 
3 men and 4 female healthy non-
diabetics, non-smoking, non-
medicated, normal-weight volunteers 
26.3+1.2 
years 
50 g glucose vs  
50 g dehydrated nopal 
Before meals 
and 15,30, 45, 
60, 90, 120, 
and 150 min 
after meals 
231.7+17.4 vs 71.4+3.5*** 25.5+5.8 vs 7.8+1.0* 76.3+13.4 vs 12.5+17.3*** 
Study 2 
n=21 
4 men and 10 w diagnosed with type 
2 diabetes with durations of <8 years 
and BMI <30 
48+2.1 years 
HCB vs 
 HCB + 300 g 
steamed nopal 
443+49 vs 287+30** 7,313+1091 vs 5,953+834* n.s. 
HSPB vs  
HSPB + 300 g 
steamed nopal 
n.s.a n.s. 1744+258 vs 2,448+229** 
4 men and 3 female healthy non-
diabetics, non-smoking, non-
medicated, normal-weight volunteers 
22.2+0.6 
years 
HCB vs 
HCB + 300 g 
steamed nopal 
120.7+1.8 vs 106.3+5.4* n.s. 8,252+1,171 vs 2,842+802** 
HSPB vs 
HSPB + 300 g 
steamed nopal 
n.s.a n.s. n.s. 
a There was no significant difference between the HSPB with and without nopal, however, the HSPB with and without nopal produced a smaller postprandial blood glucose peak than the 
HCB (P <0.001); and therefore, was more effective in reducing postprandial glucose peak. 
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Table IV. Wolfram et al (2002)1 
 
Study Characteristics 
Outcomes: Comparing changes in outcomes between data  
(n.s = not significant; *Significant p-values <0.01 & **Significant p-values <0.005) 
Groups Patient Population Age in Years 
Study 
Length 
Prickly Pear Supplement 
Blood 
Glucose 
(mmol/L) 
Insulin 
(pmol/L) 
TG 
(mmol/L) 
Total CH 
(mmol/L) 
LDL-CH 
(mmol/L) 
HDL-CH 
(mmol/L) 
Apo B 
(mmol/L) 
Uric 
Acid 
Group A 
n=12 
 
Non-obese males with 
Hypercholesterolemia 
 
35-55  
[mean 45+4.7] 
16 
weeksa 
Controlled 7506 KJ diet vs 
Controlled 7506 KJ diet 
with 625 KJ replaced with 
of 250 g/day of prickly pear 
edible pulp consumed for 8 
weeks 
5.1 vs 
4.49**b 
72.6 vs 
62**b 
n.s. 
7.2 vs 
6.4**c 
5.3 vs 
4.5**c 
1.27 vs 
1.31*d 
24.9 vs 
22.5**d 
364 vs 
341**b 
Group B 
n=12 
 
Non-obese males with 
hypercholesterolemia 
& hyperlipidemia 
 
5.27 vs 
4.8**b 
n.s. n.s. 
7.2 vs 
6.3**c 
4.4 vs 
3.75**c 
n.s. 
27.9 vs 
24.4**d 
340 vs 
289**b 
a Phase 1: first 8 weeks with controlled 7506 KJ diet. Phase 2: Replaced 625 KJ with 250 g/day of prickly pear edible pulp consumed for 8 weeks. 
b Outcome results estimated from Figure 3. Blood Glucose, Insulin and Uric Acid. 
c Outcome results estimated from Figure 1. Total Cholesterol, Triglycerides, LDL-cholesterol and Fibrinogen.  
d Outcome results estimated from Figure 2. HDL-Cholesterol and Apolipoprotein B. 
 
  
 
